Twelve Week Treatment Regimen Reduces Facial Redness | Health, Medicine and Fitness

Physician Information Staff

FRIDAY, July 1, 2022 (HealthDay News) — According to a study published online May 31 in the Journal of Cosmetic Dermatology.

Ellen O. Turner, MD, of the Dallas Office of Dermatology, conducted a 12-week open-label clinical trial to examine the efficacy and tolerability of a topical facial regimen for the treatment of facial redness and sensitive skin. Healthy men and women, ages 25 to 60, with Fitzpatrick skin types I to VI, who sought treatment for moderate or severe facial redness were enrolled. Products were provided which were applied every morning and evening.

Turner found that at weeks 8 and 12, the mean overall redness scale score improved by 34 and 25 percent, respectively. Mild to moderate improvement was seen in Global Improvement Scale scores from week two onwards; at week 12, more than 50% had a marked improvement. All subjects agreed or strongly agreed that at week 12 their facial redness was less noticeable, their skin appeared less inflamed, there was an improvement in the general appearance of the skin, and their skin had l looked and felt healthier. The treatment regimen was well tolerated.

People also read…

“The results of this 12-week study indicated that a treatment regimen designed to neutralize skin redness, calm inflamed skin, and provide sun protection was well tolerated and improved visible and physical symptoms of sensitive skin,” writes Turner. .

The research was funded by Colorescience, the maker of the products used in the study.

Originally published on consumer.healthday.com, as part of TownNews Content Exchange.